Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis.
Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis.
复制标题
淋巴管平滑肌瘤病肺组织淋巴内皮细胞的分离与表征。
DOI:
10.1038/s41598-021-88064-3
复制
发表时间:
2021-04-16
影响因子:
4.6
通讯作者:
Seyama K
中科院分区:
文献类型:
--
作者:
Nishino K;Yoshimatsu Y;Muramatsu T;Sekimoto Y;Mitani K;Kobayashi E;Okamoto S;Ebana H;Okada Y;Kurihara M;Suzuki K;Inazawa J;Takahashi K;Watabe T;Seyama K
Lymphangioleiomyomatosis (LAM) is a rare pulmonary disease characterised by the proliferation of smooth muscle-like cells (LAM cells), and an abundance of lymphatic vessels in LAM lesions. Studies reported that vascular endothelial growth factor-D (VEGF-D) secreted by LAM cells contributes to LAM-associated lymphangiogenesis, however, the precise mechanisms of lymphangiogenesis and characteristics of lymphatic endothelial cells (LECs) in LAM lesions have not yet been elucidated. In this study, human primary-cultured LECs were obtained both from LAM-affected lung tissues (LAM-LECs) and normal lung tissues (control LECs) using fluorescence-activated cell sorting (FACS). We found that LAM-LECs had significantly higher ability of proliferation and migration compared to control LECs. VEGF-D significantly promoted migration of LECs but not proliferation of LECs in vitro. cDNA microarray and FACS analysis revealed the expression of vascular endothelial growth factor receptor (VEGFR)-3 and integrin α9 were elevated in LAM-LECs. Inhibition of VEGFR-3 suppressed proliferation and migration of LECs, and blockade of integrin α9 reduced VEGF-D-induced migration of LECs. Our data uncovered the distinct features of LAM-associated LECs, increased proliferation and migration, which may be due to higher expression of VEGFR-3 and integrin α9. Furthermore, we also found VEGF-D/VEGFR-3 and VEGF-D/ integrin α9 signaling play an important role in LAM-associated lymphangiogenesis.
登录
查看更多内容
影响因子:
3.3
作者:
Mishima, Koichi;Watabe, Tetsuro;Miyazono, Kohei
通讯作者:
Miyazono, Kohei
影响因子:
1.4
作者:
Seyama, Kuniaki;Kumasaka, Toshio;Sato, Teruhiko
通讯作者:
Sato, Teruhiko
影响因子:
--
作者:
Lorusso B;Falco A;Madeddu D;Frati C;Cavalli S;Graiani G;Gervasi A;Rinaldi L;Lagrasta C;Maselli D;Gnetti L;Silini EM;Quaini E;Ampollini L;Carbognani P;Quaini F
通讯作者:
Quaini F
DOI:
10.1056/nejmoa1100391
发表时间:
2011-04-28
期刊:
The New England journal of medicine
影响因子:
--
作者:
McCormack FX;Inoue Y;Moss J;Singer LG;Strange C;Nakata K;Barker AF;Chapman JT;Brantly ML;Stocks JM;Brown KK;Lynch JP 3rd;Goldberg HJ;Young LR;Kinder BW;Downey GP;Sullivan EJ;Colby TV;McKay RT;Cohen MM;Korbee L;Taveira-DaSilva AM;Lee HS;Krischer JP;Trapnell BC;National Institutes of Health Rare Lung Diseases Consortium;MILES Trial Group
通讯作者:
MILES Trial Group
DOI:
10.1073/pnas.95.2.548
发表时间:
1998-01-20
影响因子:
11.1
作者:
Achen, MG;Jeltsch, M;Stacker, SA
通讯作者:
Stacker, SA